Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.9%1-day move
₹35.45
prior close
₹36.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-2.8-2.8-2.8+6.9+2.3+2.9+4.4+7.2+8.6+26.7+12.5+18.6+17.0
Up moveDown movePending
AI summary
Sandu Pharmaceuticals filed a Regulation 74(5) compliance certificate for the quarter ended 31 March 2026 with BSE, CDSL, and NSDL. The certificate from its Registrar MUFG Intime India confirms that securities received for dematerialization during Q4 FY26 were processed (accepted/rejected) and listed on stock exchanges within prescribed timelines. This is a routine quarterly compliance requirement under SEBI (Depository and Participants) Regulations 2018.
Likely market impact
Routine regulatory compliance filing. No material impact on business, financials, or shareholders.